PSA: The Pharmaceutical Strategy and Alliances Conference 2017 covers topics such as:
- Right-Sizing R&D for Optimum Productivity: What Drives Growth?
- The 21st Century Big Pharma: How Much Should Industry`s Larger Players be Investing in R&D?
- After the Acquisition: Can Big Biotechs Thrive as Research Hubs Inside Big Pharma?
- Improve R&D Productivity through Better Decision-Making
- Market Access Panel: New Payment Mechanisms for Breakthrough Medicines
- The Opportunities — And Risks — For Pharma in Digital Health
- Investor Panel: Crossover Investors at the Crossroad — A Look at Valuations, the State of Biotech Exits, and Exit Strategies
- Commercial Panel: Innovating in "Mature" Markets and Finding Your Niche
- Making Sure the Drug Price is Right
- Business Development Panel: Checkpoint, Please! Dealmaking Intensifies in Oncology
- Taking Stock of Development Incentives: QIDP and Breakthrough Designation
- Biosimilars are Here. Now What?
PSA: The Pharmaceutical Strategy and Alliances Conference 2017 brings together senior attendees from the pharmaceuticals industry.